Sarah Garner
@drsarahgarner
Followers
621
Following
586
Media
134
Statuses
985
Pharmacist specializing in global access issues. Likes exploring, knitting and cheese. Tweets personal.
Copenhagen, Denmark
Joined April 2013
What keeps ministers “up at night”? Important lunch discussion on day 1 with our delegations at #TallinnCharter2023: ✅ securing trust ✅ spearheading transformation of emergency services ✅ crucial collaboration between PHC & hospitals = essential for quality services
0
4
17
In today's challenging times, stretched budgets & emerging issues underscore the urgency of resilient health systems. Securing an uninterrupted supply of essential medicines is vital. We need to break free from the boxes we've confined ourselves to & explore innovative solutions.
1
2
3
Attending #TallinnCharter2023 and heard about the #Genomics programme in #Estonia in the first plenary and want to learn more? Come to our parallel session on precision medicine for #patientcenteredcare at 14:00 tomorrow. #trust #transformation @drsarahgarner @natasha_azzmus
"We all need to weave the carpet of trust together. Otherwise, our efforts to build trust on one front may falter if trust is eroded elsewhere." Sirje Karis, First Lady of Estonia opening the #TallinnCharter2023 conference 💪 @SoMinEstonia @OBShealth
1
2
4
.@WHO welcomes @POTUS' commitment to make medicines accessible and affordable to the American people. Countries should use all legal tools available to promote timely, affordable access for all in need. #HealthForAll
Folks, right now, 25 of the largest pharmaceutical companies in America control 70% of the market. This lack of competition drives up prices – making it harder for hardworking American families to access the health care they need. Today, my Administration is doing something
55
69
116
3 days to go till our 6th #AccesstoMedicines Forum! Explore crucial topics like pharmaceutical legislation, antibiotic development & fair pricing & listen to insights from our ten distinguished speakers. 📆8 Dec 🕤9:30-13:00 CET Have you registered yet?🔗 https://t.co/Wtne8U8CGY
0
6
10
We cannot build trust and transform our health systems without transparency. Aligning with the theme of the #TallinnCharter2023 conference, we're uniting stakeholders, patients, professionals, and politicians to 🤝 co-create solutions for #access2meds ⏩
0
1
0
Engaged in fruitful discussions at @WHO_Europe’s Access to Novel Medicines Platform, Working Group 1 meeting yesterday. Emphasized the need for 🤝multistakeholder actions to enhance transparency, build trust & ensure affordable & sustainable pipeline for novel high-cost meds.
1
4
11
FDA warns of "serious risk" that CAR-T can cause secondary cancers. While @US_FDA says benefits continue to outweigh risks, this is important & sobering news for those of us multiple myeloma patients who are likely candidates for CAR-T at some point.
fda.gov
FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or CD19-directed autologous CAR T cell...
0
1
5
#COVID19 continues to spread and endanger people's lives. For those who never received a COVID-19 vaccine, at least one dose is recommended. Consult your local health worker. More information: https://t.co/J24IdagZVY
1K
271
485
3 days to #Transparency meeting of @WHO_Europe #WHONMP Access to Novel Medicines multi stakeholder Platform. Thankyou chair @FrancisArickx and host @RIZIV_INAMI. For discussion: What information can be made more available and how ? @TShealthpolicy @natasha_azzmus @LDelaney18
1
3
6
@jaime_net @drsarahgarner @DavidEpsteinGRX Thanks @jaime_net!! The merit is very much yours too!! For those interested in reading the paper, let me share the link to it (it is open access):
0
2
3
Congratulations @JCRejonParrilla and colleagues. Very good insights on the drivers of variations in across countries.
Very excited to be discussing the results of this research at ISPOR Europe. We're at board 3078 until 17.00. Please do pop-by! #ISPOREurope
1
0
2
Very excited to be discussing the results of this research at ISPOR Europe. We're at board 3078 until 17.00. Please do pop-by! #ISPOREurope
1
1
13
Yesterday marked a crucial day for people's access to novel medicines in Europe & Central Asia. Our @WHO_Europe Novel Medicines Platform #WHONMP kicked off in Prague, with the first WG meeting on #Solidarity, co-hosted by 🇨🇿Min. @_DvoracekJakub. https://t.co/adR1pJ4ycx
1
1
7
United in grief - and gratitude. Today at 930am, I and the rest of @WHO_Europe joined other UN colleagues at @UNCityCPH and worldwide in a minute of silence in honour of our >100 @UN personnel killed while selflessly serving the civilians of #Gaza. We owe them so much. 🙏🌺
3
20
60
My last meeting of the #EU2023SE. How to make the vision of precision medicine ( and diagnostics) a reality. My take home message is collaboration is key and @WHO_Europe #NMP can support. Thank you Sweden and @NinaRawal for excellent chairing.
1
2
6
Honored to participate in the panel discussion along with distinguished experts on improving medicine coverage in countries. Excited to share insights and learn from others #WHOBarcelona @TayaraAl @TriinHabicht @TamasEvetovits @drsarahgarner @WHO_Europe_RU @WHOKyrgyzstan
0
2
9
@josepfigueras @dimitrapanteli @sweden2023eu @jakobforssmed @LSEHealthPolicy @EU_Commission @roserdomenech @EU_Health The risk of losing antibiotics that we have is very real. We need to harness our systems to ensure we keep them. We need to develop models to make new antibiotics accessible🌍. @KeesDeJoncheere on behalf of @drsarahgarner @WHO_Europe from📘expert group https://t.co/NpcRHTVdGN
1
2
4